199 related articles for article (PubMed ID: 2661048)
1. In vivo insulin resistance during nonlethal hypermetabolic sepsis.
Lang CH; Dobrescu C
Circ Shock; 1989 Jun; 28(2):165-78. PubMed ID: 2661048
[TBL] [Abstract][Full Text] [Related]
2. Importance of hyperglucagonemia in eliciting the sepsis-induced increase in glucose production.
Lang CH; Bagby GJ; Blakesley HL; Spitzer JJ
Circ Shock; 1989 Nov; 29(3):181-91. PubMed ID: 2574079
[TBL] [Abstract][Full Text] [Related]
3. Glucose kinetics and pyruvate dehydrogenase activity in septic rats treated with dichloroacetate.
Lang CH; Bagby GJ; Blakesley HL; Spitzer JJ
Circ Shock; 1987; 23(2):131-41. PubMed ID: 3315289
[TBL] [Abstract][Full Text] [Related]
4. Hepatic insulin resistance during canine sepsis.
McLane MP; Tomasik TW; Law WR; Raymond RM
Circ Shock; 1991 Apr; 33(4):207-15. PubMed ID: 2065441
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of eicosanoid production by BW755C does not attenuate sepsis-induced alterations in glucose kinetics.
Lang CH; Bagby GJ; Blakesley HL; Spitzer JJ
Circ Shock; 1987; 22(2):105-13. PubMed ID: 3109759
[TBL] [Abstract][Full Text] [Related]
6. Hepatic insulin resistance during chronic hyperdynamic sepsis.
Zenni GC; McLane MP; Law WR; Raymond RM
Circ Shock; 1992 Jul; 37(3):198-208. PubMed ID: 1423910
[TBL] [Abstract][Full Text] [Related]
7. Sepsis-induced increases in glucose uptake by macrophage-rich tissues persist during hypoglycemia.
Lang CH; Dobrescu C
Metabolism; 1991 Jun; 40(6):585-93. PubMed ID: 1678134
[TBL] [Abstract][Full Text] [Related]
8. Sepsis-induced changes in in vivo insulin action in diabetic rats.
Lang CH; Dobrescu C
Am J Physiol; 1989 Sep; 257(3 Pt 1):E301-8. PubMed ID: 2675627
[TBL] [Abstract][Full Text] [Related]
9. An in vivo and in vitro study of the mechanism of prednisone-induced insulin resistance in healthy subjects.
Pagano G; Cavallo-Perin P; Cassader M; Bruno A; Ozzello A; Masciola P; Dall'omo AM; Imbimbo B
J Clin Invest; 1983 Nov; 72(5):1814-20. PubMed ID: 6355186
[TBL] [Abstract][Full Text] [Related]
10. [Effect of free fatty acid-induced insulin resistance on plasma ghrelin level: an experimental study with rats].
Li L; Yang GY
Zhonghua Yi Xue Za Zhi; 2004 Oct; 84(19):1645-8. PubMed ID: 15569462
[TBL] [Abstract][Full Text] [Related]
11. Liver-selective glucocorticoid receptor antagonism decreases glucose production and increases glucose disposal, ameliorating insulin resistance.
Zinker B; Mika A; Nguyen P; Wilcox D; Ohman L; von Geldern TW; Opgenorth T; Jacobson P
Metabolism; 2007 Mar; 56(3):380-7. PubMed ID: 17292727
[TBL] [Abstract][Full Text] [Related]
12. Gram-negative infection increases noninsulin-mediated glucose disposal.
Lang CH; Dobrescu C
Endocrinology; 1991 Feb; 128(2):645-53. PubMed ID: 1989854
[TBL] [Abstract][Full Text] [Related]
13. Insulin-mediated glucose uptake by individual tissues during sepsis.
Lang CH; Dobrescu C; Mészáros K
Metabolism; 1990 Oct; 39(10):1096-107. PubMed ID: 2215256
[TBL] [Abstract][Full Text] [Related]
14. Effect of subcutaneous Escherichia coli-induced hypermetabolic sepsis on hepatic gluconeogenesis and its hormonal responsiveness in the rat.
Deaciuc IV; Lang CH; Bagby GJ; Spitzer JJ
Circ Shock; 1993 Oct; 41(2):82-7. PubMed ID: 8242884
[TBL] [Abstract][Full Text] [Related]
15. Insulin sensitivity in adult female rats subjected to malnutrition during the perinatal period.
Holemans K; Verhaeghe J; Dequeker J; Van Assche FA
J Soc Gynecol Investig; 1996; 3(2):71-7. PubMed ID: 8796811
[TBL] [Abstract][Full Text] [Related]
16. S26948, a new specific peroxisome proliferator activated receptor gamma modulator improved in vivo hepatic insulin sensitivity in 48 h lipid infused rats.
Sohn KA; Cruciani-Guglielmacci C; Kassis N; Clément L; Ouali F; Caüzac M; Lebègue N; Berthelot P; Caignard DH; Pégorier JP; Renard P; Dacquet C; Ktorza A; Magnan C;
Eur J Pharmacol; 2009 Apr; 608(1-3):104-11. PubMed ID: 19250932
[TBL] [Abstract][Full Text] [Related]
17. Epinephrine-induced insulin resistance in man.
Deibert DC; DeFronzo RA
J Clin Invest; 1980 Mar; 65(3):717-21. PubMed ID: 6243677
[TBL] [Abstract][Full Text] [Related]
18. FK-614, a selective peroxisome proliferator-activated receptor gamma agonist, improves peripheral glucose utilization while decreasing hepatic insulin extraction in alloxan-induced diabetic dogs.
Uchino H; Kim T; Lam TK; Yoshii H; Klement P; Williams W; Kawamori R; Giacca A
Metabolism; 2005 Sep; 54(9):1250-8. PubMed ID: 16125538
[TBL] [Abstract][Full Text] [Related]
19. Infection impairs insulin-dependent hepatic glucose uptake during total parenteral nutrition.
Donmoyer CM; Chen SS; Lacy DB; Pearson DA; Poole A; Zhang Y; McGuinness OP
Am J Physiol Endocrinol Metab; 2003 Mar; 284(3):E574-82. PubMed ID: 12441309
[TBL] [Abstract][Full Text] [Related]
20. Free fatty acid-induced hepatic insulin resistance: a potential role for protein kinase C-delta.
Lam TK; Yoshii H; Haber CA; Bogdanovic E; Lam L; Fantus IG; Giacca A
Am J Physiol Endocrinol Metab; 2002 Oct; 283(4):E682-91. PubMed ID: 12217885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
